TDO2 Rekombinanter Antikörper

TDO2 Rekombinant Antikörper für WB, Cytometric bead array, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Ratte

Anwendung

WB, Cytometric bead array, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

240068C2

Kat-Nr. : 83236-2-PBS

Synonyme

240068C2, EC:1.13.11.11, TDO, TO, TPH2



Geprüfte Anwendungen

Produktinformation

83236-2-PBS bindet in WB, Cytometric bead array, Indirect ELISA TDO2 und zeigt Reaktivität mit human, Ratten

Getestete Reaktivität human, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen TDO2 fusion protein Ag8531
Vollständiger Name tryptophan 2,3-dioxygenase
Berechnetes Molekulargewicht 406 aa, 48 kDa
Beobachtetes Molekulargewicht 40-50 kDa
GenBank-ZugangsnummerBC005355
Gene symbol TDO2
Gene ID (NCBI) 6999
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

TDO2 (tryptophan 2,3-dioxygenase), IDO1 (indoleamine 2,3-dioxygenase 1) and IDO2 are three enzymes that catalyze the amino acid tryptophan into kynurenine in the kynurenine pathway (PMID: 23090118, 28469468). TDO2 plays an important role in neurological diseases such as Alzheimer's disease, Parkinson's disease and autism. Overexpression of TDO2 promoted tumor cell survival and was correlated with tumor grade and poor prognosis in triple negative breast cancer, brain tumors and esophageal squamous cell carcinoma. TDO2 may be a potential therapeutic target in some cancers. (PMID: 21976023, 30134247)